Sodium glucose co-transporter 2 inhibitor prevents nephrolithiasis in non-diabetes by restoring impaired autophagic flux
This research was funded by grants from the National Science and Technology Council, Taiwan (110-2314-B-006-023, 110-2320-B-006-017MY3, and 112-2314-B-006-058) and the research grants (NCKUH-11202005, -11210020) from the National Cheng Kung University Hospital, Tainan, Taiwan.
Authors
- Miyuki Hsing‐Chun Hsieh (ORCID: https://orcid.org/0000-0002-7995-7408)
- Edward Chia‐Cheng Lai (ORCID: https://orcid.org/0000-0002-5852-7652)
- Chan-Jung Liu (ORCID: https://orcid.org/0000-0002-3929-286X)
- Kuo-Ting Ho (ORCID: https://orcid.org/0000-0001-7224-1338)
- Yau‐Sheng Tsai (ORCID: https://orcid.org/0000-0002-5560-2661)
- Ze‐Hong Lu (ORCID: https://orcid.org/0000-0002-3605-2369)
- Yu-Shan Chang (ORCID: https://orcid.org/0000-0003-4143-9047)
- Ho‐Shiang Huang (ORCID: https://orcid.org/0000-0002-8852-7004)
- Wei-Hsuan Wang
Institutions
- Chi Mei Medical Center (TW)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1016/j.ebiom.2025.105668
- Citations
- 7
- Primary Topic
- Biomedical Research and Pathophysiology
- Type
- article
- Field-Weighted Citation Impact
- 10.30
Funders
- Ministry of Science and Technology, Taiwan
- National Cheng Kung University Hospital